Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024
Compare Profit and Loss Results of Novartis India
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
356.00
835.00
-479.00
-57.37%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
52.00
-52.00
-100.00%
Net Sales
356.00
782.00
-426.00
-54.48%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-64.00
67.00
104.69%
Raw Materials Consumed
199.00
500.00
-301.00
-60.20%
Power & Fuel Cost
0.00
56.00
-56.00
-100.00%
Employee Cost
18.00
80.00
-62.00
-77.50%
Operating Expenses
8.00
29.00
-21.00
-72.41%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
13.00
-3.00
-23.08%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
9.00
2.00
7.00
350.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
264.00
642.00
-378.00
-58.88%
Operating Profit (PBDIT) excl Other Income
91.00
139.00
-48.00
-34.53%
Other Income
41.00
6.00
35.00
583.33%
Operating Profit (PBDIT)
133.00
146.00
-13.00
-8.90%
Interest
0.00
18.00
-18.00
-100.00%
Profit before Depriciation and Tax
132.00
127.00
5.00
3.94%
Depreciation
2.00
34.00
-32.00
-94.12%
Profit Before Taxation & Exceptional Items
130.00
93.00
37.00
39.78%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
130.00
93.00
37.00
39.78%
Provision for Tax
29.00
24.00
5.00
20.83%
Profit After Tax
100.00
68.00
32.00
47.06%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
728.00
359.00
369.00
102.79%
Profit Available for appropriations
829.00
427.00
402.00
94.15%
Appropriations
829.00
427.00
402.00
94.15%
Equity Dividend (%)
500%
40%
460.00
Earnings Per Share
40.87
8.07
32.80
406.44%
Profit And Loss - Net Sales
Net Sales 356.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 91.42 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024
Profit And Loss - Interest
Interest 0.77 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 100.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024
